NOVOZYMES A/S — Credit Rating and Financial Key Figures

NOVOZYMES A/S (CVR number: 10007127K) is a company from GLADSAXE. The company reported a net sales of 4157.6 mDKK in 2025, demonstrating a growth of 8.5 % compared to the previous year. The operating profit percentage was at 19.6 % (EBIT: 816.7 mDKK), while net earnings were 583.6 mDKK. The profitability of the company measured by Return on Assets (ROA) was 5.4 %, which can be considered decent and Return on Equity (ROE) was 5.3 %, which can be considered decent. The equity ratio, a key indicator for solidity, stood at 66.4 %, a level that can be considered to be good. This shows that a large part of the company's assets are funded by shareholders' equity, reducing financial risk. NOVOZYMES A/S's liquidity measured by quick ratio was 0.4 which is at a very low level. Thus, the company is in an unstable financial position, with its liquid assets significantly undermatching its current liabilities. This severe liquidity deficiency may lead to financial distress and threaten the company's operational continuity.